This topic contains a solution. Click here to go to the answer

Author Question: Which is true about A. sediba? a. It was found in East Africa. b. It dates at least to 3.9 mya. ... (Read 76 times)

mcmcdaniel

  • Hero Member
  • *****
  • Posts: 550
Which is true about A. sediba?
 
  a. It was found in East Africa.
  b. It dates at least to 3.9 mya.
  c. It shows a mix of Australopithecus and Homo features.
  d. It has a small brain at 320 cm3.
  e. It was mainly a carnivore.

Question 2

The oldest Paranthropus fossil
 
  a. dated to 1.8 mya.
  b. was discovered at Hadar.
  c. is nicknamed the black skull..
  d. was a 50 percent complete skeleton.
  e. was in the form of foot remains.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

c

Answer to Question 2

c





 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Famous people who died from poisoning or drug overdose include, Adolf Hitler, Socrates, Juan Ponce de Leon, Marilyn Monroe, Judy Garland, and John Belushi.

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library